Abnormal DNA methylation is considered as an important epigenetic marker in melanoma pathogenesis [9] and dysexpression of methyltransferases such as DNMT3B, can alter methylation pattern in genes promoter [10, 11]. This evidence concerns the gene DNMT3B and melanoma.